Vital medicines funding needed now for all our NHS patients
By Alan Bullion
Ahead of the June general election, our pharmaceutical industry has warned that the UK risks becoming a "desert for healthcare innovation" if the next government fails to invest sufficient resources. New medicines and clinical trials might have to be delayed.
The Association of the British Pharmaceutical Industry (ABPI) calls for an increase in health spending from 9.9% to 11% of GDP - which amounts to a sum of £20bn a year.
Lisa Anson, president of the ABPI commented: "This General Election comes at a critical juncture. Do we want to improve NHS patient outcomes and ensure Britain continues to be a global player in Life Sciences, or run the risk of the UK becoming a desert for healthcare innovation?"
This is yet another crucially important economic and employment sector that could suffer competitively post-Brexit without the strategic investment to deliver vital new drugs and products for our NHS patients.
The Lib Dems have called for a penny on income tax. NHS Providers have also said that our health service needs a cash injection of £25 billon before 2020, or risk further decline in the quality of service and longer waiting times for treatment. We need the money now.
It is estimated that nurses wages could fall by 12% over the next decade, leading to 42,0000 nursing job losses. Many nurses are already having to visit food banks and take pay day loans to survive, a scandal in modern Tory Btitain, where our vital health services are being starved of cash.
Remember the Leave line about the Brexit bus that would deliver £350 million a week to our economy if the UK left the EU? A picture can be found below. The Tory driver is meanwhile still missing in action....